Literature DB >> 15205162

Direct percutaneous intratumoral bleomycin injection for palliative treatment of impending quadriplegia.

Ian C Duncan1, Pieter A Fourie, Albert S Alberts.   

Abstract

We describe a case of midcervical angiosarcoma causing compression of the cervical spinal cord, producing rapidly progressive neurologic deficits. The tumor had recurred despite previous resection and was refractory to radiation and chemotherapy. Shrinkage of the tumor by percutaneous embolization was not considered feasible. A single direct percutaneous intratumoral injection of 15 U of bleomycin produced sufficient tumor shrinkage to relieve the pressure on the spinal cord and thereby reverse some of the neurologic deficits and give adequate palliation against recurrence of this problem for the remainder of the patient's life. Direct percutaneous intratumoral injection of bleomycin may thus be considered for palliation when other treatment methods have failed to elicit a suitable clinical response.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15205162      PMCID: PMC7975668     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  13 in total

1.  Treatment of hemangioma with an angiogenesis inhibitor pingyangmycin.

Authors:  W Licun; S Gongjia
Journal:  Indian Pediatr       Date:  2000-06       Impact factor: 1.411

2.  Direct injection of anti-cancer drugs into endobronchial tumours for palliation of major airway obstruction.

Authors:  S I Celikoğlu; T Karayel; S Demirci; F Celikoğlu; T Cağatay
Journal:  Postgrad Med J       Date:  1997-03       Impact factor: 2.401

3.  A phase I trial of continuously infused intratumoral bleomycin for the treatment of recurrent glioblastoma multiforme.

Authors:  Roy A Patchell; William F Regine; Paul Ashton; Phillip A Tibbs; Diane Wilson; Diana Shappley; Byron Young
Journal:  J Neurooncol       Date:  2002-10       Impact factor: 4.130

4.  Efficacy of bleomycin treatment for symptomatic hemangiomas in children.

Authors:  C M Kullendorff
Journal:  Pediatr Surg Int       Date:  1997-09       Impact factor: 1.827

5.  Inhibition of angiogenesis by bleomycin and its copper complex.

Authors:  T Oikawa; K Hirotani; H Ogasawara; T Katayama; H Ashino-Fuse; M Shimamura; T Iwaguchi; O Nakamura
Journal:  Chem Pharm Bull (Tokyo)       Date:  1990-06       Impact factor: 1.645

Review 6.  A radical approach to cancer.

Authors:  Undurti Das
Journal:  Med Sci Monit       Date:  2002-04

7.  [Treatment of hemangioma in oral and maxillofacial region with pingyangmycin injection].

Authors:  C Wang; Q Gao; F Fu; Y Wen; X Dai; H Gong; X Lu
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2000-10

8.  Bleomycin.

Authors:  J M Bennett; S D Reich
Journal:  Ann Intern Med       Date:  1979-06       Impact factor: 25.391

Review 9.  Intralesional bleomycin injection (IBI) treatment for haemangiomas and congenital vascular malformations.

Authors:  T Muir; M Kirsten; P Fourie; N Dippenaar; G O Ionescu
Journal:  Pediatr Surg Int       Date:  2004-01-22       Impact factor: 1.827

10.  Sclerotherapy for lymphangioma in children.

Authors:  I Sanlialp; I Karnak; F C Tanyel; M E Senocak; N Büyükpamukçu
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2003-07       Impact factor: 1.675

View more
  3 in total

1.  TACE plus percutaneous chemotherapy-lipiodol treatment of unresectable pedunculated hepatocellular carcinoma.

Authors:  Dexiao Huang; Yong Chen; Shuo Chen; Qingle Zeng; Jianbo Zhao; Renhua Wu; Yanhao Li
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

2.  Improving antitumor outcomes for palliative intratumoral injection therapy through lecithin- chitosan nanoparticles loading paclitaxel- cholesterol complex.

Authors:  Xiao-Yang Chu; Wei Huang; Yu-Li Wang; Ling-Wei Meng; Li-Qing Chen; Ming-Ji Jin; Lu Chen; Chun-Hong Gao; Cheng Ge; Zhong-Gao Gao; Chun-Sheng Gao
Journal:  Int J Nanomedicine       Date:  2019-01-23

Review 3.  Delivery of Nanoparticle-Based Radiosensitizers for Radiotherapy Applications.

Authors:  Francis Boateng; Wilfred Ngwa
Journal:  Int J Mol Sci       Date:  2019-12-31       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.